Nurix Therapeutics, Inc. (NRIX)
26.27
-0.45
(-1.68%)
USD |
NASDAQ |
Aug 24, 16:00
26.35
+0.08
(+0.30%)
After-Hours: 06:00
Nurix Therapeutics Gross Profit Margin (Quarterly) : 57.43% for May 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 57.43% |
| February 28, 2026 | 39.60% |
| November 30, 2025 | 65.89% |
| August 31, 2025 | 36.66% |
| May 31, 2025 | 88.43% |
| February 28, 2025 | 77.63% |
| November 30, 2024 | 67.61% |
| August 31, 2024 | 67.06% |
| May 31, 2024 | 66.17% |
| February 29, 2024 | 76.56% |
| November 30, 2023 | 75.22% |
| August 31, 2023 | 81.68% |
| May 31, 2023 | 89.13% |
| February 28, 2023 | 74.93% |
| November 30, 2022 | 55.23% |
| Date | Value |
|---|---|
| August 31, 2022 | 73.26% |
| May 31, 2022 | 76.98% |
| February 28, 2022 | 76.58% |
| November 30, 2021 | 89.76% |
| August 31, 2021 | 0.00% |
| May 31, 2021 | 0.00% |
| February 28, 2021 | 0.00% |
| November 30, 2020 | 0.00% |
| August 31, 2020 | 0.00% |
| May 31, 2020 | 0.00% |
| February 29, 2020 | 0.00% |
| November 30, 2019 | 0.00% |
| August 31, 2019 | 0.00% |
| May 31, 2019 | 0.00% |
| February 28, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | 78.69% |
| Gilead Sciences, Inc. | 79.81% |
| TG Therapeutics, Inc. | 82.86% |
| Cue Biopharma, Inc. | 99.54% |
| Keros Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -76.12% |
| Return on Assets | -57.12% |
| Return on Invested Capital | -67.65% |
| Profit Margin (Quarterly) | -990.1% |
| Operating Margin (Quarterly) | -1.04K% |
| Return on Net Operating Assets | -451.5% |